7 March 2022 Clinical Neurology Pharmaceuticals

Alzheimer’s drug ‘unproven, costly, risky’

12 November 2021 Clinical Neurology

Alzheimer’s: addressing the metabolic abnormality

10 November 2021 Clinical Neurology

Alzheimer’s: an update on diagnosis and management

16 July 2021 Clinical Drugs Neurology

FDA calls watchdog on itself over aducanumab

8 July 2021 Clinical Neurology

Doubts cloud costly Alzheimer’s drug

25 June 2020 Gastro Mental Health Research

Dementia risk doubles for people with IBD

5 June 2020 Clinical Mental Health Neurology Research

A blood test for Alzheimer’s – is it that simple?

Sponsored {{ ::category.name }}

Brought to you by {{ ::post.advertiser.name }}